{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T07:56:48Z","timestamp":1788508608928,"version":"build-2803163510"},"reference-count":27,"publisher":"The Society for Free Radical Research Japan","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Clin. Biochem. Nutr."],"published-print":{"date-parts":[[2021,3,1]]},"DOI":"10.3164\/jcbn.20-142","type":"journal-article","created":{"date-parts":[[2021,1,15]],"date-time":"2021-01-15T22:09:20Z","timestamp":1610748560000},"page":"181-186","source":"Crossref","is-referenced-by-count":25,"title":["Vitamin B6 efficacy in the treatment of nonalcoholic fatty liver disease: an open-label, single-arm, single-center trial"],"prefix":"10.3164","volume":"68","author":[{"given":"Takashi","family":"Kobayashi","sequence":"first","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Yokohama City University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takaomi","family":"Kessoku","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Yokohama City University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Ozaki","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Yokohama City University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michihiro","family":"Iwaki","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Yokohama City University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasushi","family":"Honda","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Yokohama City University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuji","family":"Ogawa","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Yokohama City University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kento","family":"Imajo","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Yokohama City University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masato","family":"Yoneda","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Yokohama City University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoru","family":"Saito","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Yokohama City University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Nakajima","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Yokohama City University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1739","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1 Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M.  Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology 2016; 64: 73\u201384.","DOI":"10.1002\/hep.28431"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Neuschwander-Tetri BA, Caldwell SH. Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference. Hepatology 2003; 37: 1202\u20131219.","DOI":"10.1053\/jhep.2003.50193"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Rosenberg J, Ischebeck T, Commichau FM. Vitamin B6 metabolism in microbes and approaches for fermentative production. Biotechnol Adv 2017; 35: 31\u201340.","DOI":"10.1016\/j.biotechadv.2016.11.004"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Page JH, Ma J, Chiuve SE, et al. Plasma vitamin B6 and risk of myocardial infarction in women. Circulation 2009; 120: 649\u2013655.","DOI":"10.1161\/CIRCULATIONAHA.108.809038"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5 Kelly PJ, Shih VE, Kistler JP, et al. Low vitamin B6 but not homocysteine is associated with increased risk of stroke and transient ischemic attack in the era of folic acid grain fortification. Stroke 2003; 34: e51\u2013e54.","DOI":"10.1161\/01.STR.0000071109.23410.AB"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Hron G, Lombardi R, Eichinger S, Lecchi A, Kyrle PA, Cattaneo M. Low vitamin B6 levels and the risk of recurrent venous thromboembolism. Haematologica 2007; 92: 1250\u20131253.","DOI":"10.3324\/haematol.11318"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Chiang EP, Bagley PJ, Selhub J, Nadeau M, Roubenoff R. Abnormal vitamin B<sub>6<\/sub> status is associated with severity of symptoms in patients with rheumatoid arthritis. Am J Med 2003; 114: 283\u2013287.","DOI":"10.1016\/S0002-9343(02)01528-0"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Selhub J, Byun A, Liu Z, Mason JB, Bronson RT, Crott JW. Dietary vitamin B6 intake modulates colonic inflammation in the IL10\u2013\/\u2013 model of inflammatory bowel disease. J Nutr Biochem 2013; 24: 2138\u20132143.","DOI":"10.1016\/j.jnutbio.2013.08.005"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Friedman AN, Hunsicker LG, Selhub J, Bostom AG. Clinical and nutritional correlates of C-reactive protein in type 2 diabetic nephropathy. Atherosclerosis 2004; 172: 121\u2013125.","DOI":"10.1016\/j.atherosclerosis.2003.09.011"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Larsson SC, Orsini N, Wolk A. Vitamin B6 and risk of colorectal cancer: a meta-analysis of prospective studies. JAMA 2010; 303: 1077\u20131083.","DOI":"10.1001\/jama.2010.263"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Johansson M, Relton C, Ueland PM, et al. Serum B vitamin levels and risk of lung cancer. JAMA 2010; 303: 2377\u20132385.","DOI":"10.1001\/jama.2010.808"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 Ferro Y, Car\u00e8 I, Mazza E, et al. Protein and vitamin B6 intake are associated with liver steatosis assessed by transient elastography, especially in obese individuals. Clin Mol Hepatol 2017; 23: 249\u2013259.","DOI":"10.3350\/cmh.2017.0019"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Federico A, Dallio M, Caprio GG, et al. Qualitative and quantitative evaluation of dietary intake in patients with non-alcoholic steatohepatitis. Nutrients 2017; 9: 1074.","DOI":"10.3390\/nu9101074"},{"key":"14","unstructured":"14 Liu Z, Li P, Zhao ZH, Zhang Y, Ma ZM, Wang SX. Vitamin B6 prevents endothelial dysfunction, insulin resistance, and hepatic lipid accumulation in Apoe (\u2013\/\u2013) mice fed with high-fat diet. J Diabetes Res 2016; 2016: 1748065."},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 Imajo K, Kessoku T, Honda Y, et al. Magnetic resonance imaging more accurately classifies steatosis and fibrosis in patients with nonalcoholic fatty liver disease than transient elastography. Gastroenterology 2016; 150: 626\u2013637.e7.","DOI":"10.1053\/j.gastro.2015.11.048"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16 Shah AG, Lydecker A, Murray K, et al. Comparison of noninvasive markers of fibrosis in patients with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol 2009; 7: 1104\u20131112.","DOI":"10.1016\/j.cgh.2009.05.033"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17 Tokuda Y, Okubo T, Ohde S, et al. Assessing items on the SF-8 Japanese version for health-related quality of life: a psychometric analysis based on the nominal categories model of item response theory. Value Health 2009; 12: 568\u2013573.","DOI":"10.1111\/j.1524-4733.2008.00449.x"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18 Neuschwander-Tetri BA, Loomba R, Sanyal AJ, et al. Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial. Lancet 2015; 385: 956\u2013965.","DOI":"10.1016\/S0140-6736(14)61933-4"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19 Nijhout HF, Gregory JF, Fitzpatrick C, et al. A mathematical model gives insights into the effects of vitamin B-6 deficiency on 1-carbon and glutathione metabolism. J Nutr 2009; 139: 784\u2013791.","DOI":"10.3945\/jn.109.104265"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20 Ai Y, Sun Z, Peng C, Liu L, Xiao X, Li J. Homocysteine induces hepatic steatosis involving ER stress response in high methionine diet-fed mice. Nutrients 2017; 9: 346.","DOI":"10.3390\/nu9040346"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21 de Carvalho SC, Muniz MT, Siqueira MD, et al. Plasmatic higher levels of homocysteine in non-alcoholic fatty liver disease (NAFLD). Nutr J 2013; 12: 37.","DOI":"10.1186\/1475-2891-12-37"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22 Gulsen M, Yesilova Z, Bagci S, et al. Elevated plasma homocysteine concentrations as a predictor of steatohepatitis in patients with non-alcoholic fatty liver disease. J Gastroenterol Hepatol 2005; 20: 1448\u20131455.","DOI":"10.1111\/j.1440-1746.2005.03891.x"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23 Maruyama K, S Eshak E, Kinuta M, et al. Association between vitamin B group supplementation with changes in % flow-mediated dilatation and plasma homocysteine levels: a randomized controlled trial. J Clin Biochem Nutr 2019; 64: 243\u2013249.","DOI":"10.3164\/jcbn.17-56"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24 Promrat K, Kleiner DE, Niemeier HM, et al. Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis. Hepatology 2010; 51: 121\u2013129.","DOI":"10.1002\/hep.23276"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25 Osaka T, Hashimoto Y, Hamaguchi M, Kojima T, Obora A, Fukui M.  Nonalcoholic fatty liver disease remission in men through regular exercise. J Clin Biochem Nutr 2018; 62: 242\u2013246.","DOI":"10.3164\/jcbn.17-115"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26 Takahashi H, Kotani K, Tanaka K, Egucih Y, Anzai K. Therapeutic approaches to nonalcoholic fatty liver disease: exercise intervention and related mechanisms. Front Endocrinol (Lausanne) 2018; 9: 588.","DOI":"10.3389\/fendo.2018.00588"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27 Lin PT, Cheng CH, Liaw YP, Lee BJ, Lee TW, Huang YC. Low pyridoxal 5&apos;-phosphate is associated with increased risk of coronary artery disease. Nutrition 2006; 22: 1146\u20131151.","DOI":"10.1016\/j.nut.2006.08.013"}],"container-title":["Journal of Clinical Biochemistry and Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jcbn\/68\/2\/68_20-142\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,6]],"date-time":"2021-03-06T03:59:06Z","timestamp":1615003146000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jcbn\/68\/2\/68_20-142\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,1]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.3164\/jcbn.20-142","relation":{},"ISSN":["0912-0009","1880-5086"],"issn-type":[{"value":"0912-0009","type":"print"},{"value":"1880-5086","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,1]]}}}